http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+13/26930043.html si-local-file:///var/storage/secattach/20260814/26930043.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+13/26930043.html Fri, 14 Aug 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+13/26930043.html si-local-file:///var/storage/secattach/20260814/26930043.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+13/26930043.html Fri, 14 Aug 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++KORU+Medical+Systems%2C+++++For%3A+Jul+28++Filed+by%3A+KALBERMATTEN+ADAM+R/26884067.html si-local-file:///var/storage/secattach/20260806/26884067.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++KORU+Medical+Systems%2C+++++For%3A+Jul+28++Filed+by%3A+KALBERMATTEN+ADAM+R/26884067.html Thu, 06 Aug 2026 16:12:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++KORU+Medical+Systems%2C+++++For%3A+Jul+28++Filed+by%3A+KALBERMATTEN+ADAM+R/26884067.html si-local-file:///var/storage/secattach/20260806/26884067.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++KORU+Medical+Systems%2C+++++For%3A+Jul+28++Filed+by%3A+KALBERMATTEN+ADAM+R/26884067.html Thu, 06 Aug 2026 16:12:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Earnings/Repro+Med+Systems+%28KRMD%29+Tops+Q2+EPS+by+4c/26875505.html <p>Repro Med Systems (NASDAQ: KRMD) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $12 million versus the consensus estimate of $11.62 million.</p><p>For earnings history and earnings-related data on Repro Med Systems (KRMD) <a href="http://www.streetinsider.com/ec_earnings.php?q=KRMD">click here</a>.</p> http://www.streetinsider.com/Earnings/Repro+Med+Systems+%28KRMD%29+Tops+Q2+EPS+by+4c/26875505.html Wed, 05 Aug 2026 16:54:15 -0400 KRMD http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++KORU+Medical+Systems%2C+++++For%3A+Jun+30/26874195.html si-local-file:///var/storage/secattach/20260805/26874195.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++KORU+Medical+Systems%2C+++++For%3A+Jun+30/26874195.html Wed, 05 Aug 2026 16:09:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++KORU+Medical+Systems%2C+++++For%3A+Jun+30/26874195.html si-local-file:///var/storage/secattach/20260805/26874195.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++KORU+Medical+Systems%2C+++++For%3A+Jun+30/26874195.html Wed, 05 Aug 2026 16:09:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2026. The Company also updated guidance for the full year 2026. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><ul class="bwlistdisc"> <li> Net revenues grew 18% over the prior year period to $12.0 million </li> </ul><ul class="bwlistdisc"> <li> Gross profit grew 20% over the prior year period to $7.8 million, with gross margin of 65.1% </li> </ul><ul class="bwlistdisc"> <li> Net income improved 222% over the http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+Announces+Second+Quarter+2026+Results+and+Updates+Full+Year+2026+Guidance/26873864.html Wed, 05 Aug 2026 16:05:00 -0400 A.06822034 KRMD O.00031240 O.20026344 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+05/26873817.html si-local-file:///var/storage/secattach/20260805/26873817.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+05/26873817.html Wed, 05 Aug 2026 16:04:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+05/26873817.html si-local-file:///var/storage/secattach/20260805/26873817.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++KORU+Medical+Systems%2C+++++For%3A+Aug+05/26873817.html Wed, 05 Aug 2026 16:04:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++144++++++++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+KALBERMATTEN+ADAM+R/26859354.html si-local-file:///var/storage/secattach/20260803/26859354.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+KALBERMATTEN+ADAM+R/26859354.html Mon, 03 Aug 2026 17:19:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++144++++++++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+KALBERMATTEN+ADAM+R/26859354.html si-local-file:///var/storage/secattach/20260803/26859354.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+KALBERMATTEN+ADAM+R/26859354.html Mon, 03 Aug 2026 17:19:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. </p><p> KORU Medical's management is scheduled to present at the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026, at 10:00 am ET.<b> </b>Interested parties can access the live and archived webcast on the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.korumedical.com%2Fnews-events&amp;esheet=54579234&amp;newsitemid=20260729652277&amp;lan=en-US&amp;anchor=News%2FEvents&amp;index=1&amp;md5=9997002c2be555611f012b022ae3d19e" shape="rect">News/Events</a> page of the Investors section of http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html Wed, 29 Jul 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. </p><p> KORU Medical's management is scheduled to present at the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026, at 10:00 am ET.<b> </b>Interested parties can access the live and archived webcast on the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.korumedical.com%2Fnews-events&amp;esheet=54579234&amp;newsitemid=20260729652277&amp;lan=en-US&amp;anchor=News%2FEvents&amp;index=1&amp;md5=9997002c2be555611f012b022ae3d19e" shape="rect">News/Events</a> page of the Investors section of http://www.streetinsider.com/Press+Releases/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html Wed, 29 Jul 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. </p><p> KORU Medical's management is scheduled to present at the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026, at 10:00 am ET.<b> </b>Interested parties can access the live and archived webcast on the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.korumedical.com%2Fnews-events&amp;esheet=54579234&amp;newsitemid=20260729652277&amp;lan=en-US&amp;anchor=News%2FEvents&amp;index=1&amp;md5=9997002c2be555611f012b022ae3d19e" shape="rect">News/Events</a> page of the Investors section of http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html Wed, 29 Jul 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html <p> MAHWAH, N.J.--(BUSINESS WIRE)-- <b>KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”),</b> a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will participate in the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026. </p><p> KORU Medical's management is scheduled to present at the Canaccord Genuity 46th Annual Growth Conference on August 12th, 2026, at 10:00 am ET.<b> </b>Interested parties can access the live and archived webcast on the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.korumedical.com%2Fnews-events&amp;esheet=54579234&amp;newsitemid=20260729652277&amp;lan=en-US&amp;anchor=News%2FEvents&amp;index=1&amp;md5=9997002c2be555611f012b022ae3d19e" shape="rect">News/Events</a> page of the Investors section of http://www.streetinsider.com/Business+Wire/KORU+Medical+Systems+to+Participate+in+the+Canaccord+Genuity+46th+Annual+Growth+Conference/26834832.html Wed, 29 Jul 2026 16:05:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834396.html si-local-file:///var/storage/secattach/20260729/26834396.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834396.html Wed, 29 Jul 2026 15:22:00 -0400 KRMD O.00031240 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834396.html si-local-file:///var/storage/secattach/20260729/26834396.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++KORU+Medical+Systems%2C++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834396.html Wed, 29 Jul 2026 15:22:00 -0400 KRMD O.00031240